Reuters |
Pharma and tech converge in 'fantastic voyage' to fight disease
Reuters LONDON The line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware. GlaxoSmithKline (GSK.L) and Google parent Alphabet (GOOGL ... GSK and Verily to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic ... |
Tuesday, 2 August 2016
Pharma and tech converge in 'fantastic voyage' to fight disease - Reuters
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment